e-learning
resources
Stockholm 2002
Sunday 15.09.2002
Prevalence and costs of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of prevalence of COPD according to different criteria
A. Lindberg, L. G. Larsson, A. C. Jonsson, B. Lundbäck (Luleå, Stockholm, Sweden)
Source:
Annual Congress 2002 - Prevalence and costs of COPD
Session:
Prevalence and costs of COPD
Session type:
Thematic Poster Session
Number:
827
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Lindberg, L. G. Larsson, A. C. Jonsson, B. Lundbäck (Luleå, Stockholm, Sweden). Evaluation of prevalence of COPD according to different criteria. Eur Respir J 2002; 20: Suppl. 38, 827
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Comparing the different diagnostic criteria of Asthma and COPD overlap
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Population based study on the prevalence of COPD by spirometric criteria
Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD
Year: 2010
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
COPD severity analysis according to current evaluation criteria – National survey
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Health status in the GOLD guidelines era. Assessing the new COPD severity staging criteria
Source: Eur Respir J 2002; 20: Suppl. 38, 251s
Year: 2002
Prevalence and clinical characteristics of asthma-COPD overlap syndrome according to accepted criteria
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
The current ERS, BTS, ATS and GOLD classification criteria underestimate the impact of COPD on patients
Source: Eur Respir J 2002; 20: Suppl. 38, 254s
Year: 2002
Effectiveness of tiotropium in low-risk patients according to new GOLD severity grading
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Population impact of different definitions of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 201s
Year: 2001
Prevalence and severity of GOLD defined COPD in adults
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002
The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Useful malnutrition diagnostic criteria for stable COPD in Japanese patients
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
The impact of using different symptom-based exacerbation definitions in COPD patients
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
Definition, epidemiology and diagnostic criteria of IPF and how these guidelines were developed
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: evidence based guidelines and recommendations for clinical management - Results of the joint ATS/ERS/JRS taskforce
Year: 2009
Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Relationship between quality of life and severity of COPD according to GOLD classification
Source: Eur Respir J 2004; 24: Suppl. 48, 15s
Year: 2004
Prevalence of comorbidities in established and newly treated patients with COPD according to GOLD 2017 in a UK primary care population
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept